<div id="readability-page-1"><div><h2>Why the latest sales update matters for Nestlé shares</h2> <p>Nestlé (SWX:NESN) reported first quarter 2026 group sales of CHF 21,317 million compared with CHF 22,601 million a year earlier, yet the stock reacted positively as investors focused on underlying organic growth and pricing.</p> <p>See our latest analysis for Nestlé.</p> <p>That positive reaction around the sales release sits against a mixed share price picture, with a 7.65% 90 day share price return contrasting with a 6.08% decline in the one year total shareholder return. This suggests improving momentum after a tougher spell.</p> <p>If this update has you rethinking where growth could come from next, it may be worth scanning other sectors and checking out 97 top founder-led companies</p> <p>With Nestlé trading at CHF 79.05, an indicated intrinsic discount of around 49% and a double digit gap to analyst targets, the key question is whether there is genuine value here or if the market is already pricing in future growth.</p> <h2>Most Popular Narrative: 9.9% Undervalued</h2> <p>On the most followed view, Nestlé's fair value of CHF 87.69 sits above the last close at CHF 79.05, putting the current discount under the spotlight.</p> <blockquote> <p><em>Sustained portfolio reshaping, particularly the strategic review of lower-growth value brands in vitamins, minerals, and supplements (VMS) and refocusing on premium, health-driven brands (for example, Garden of Life and Solgar), positions Nestlé to capture disproportionate growth from consumers' accelerating shift toward health, wellness, and science-based nutrition, which should lift top-line growth and group margins.</em></p> </blockquote> <p>Read the complete narrative.</p> <p>Curious what sits behind that premium nutrition pivot and CHF based fair value? The narrative leans on measured revenue growth, firmer margins and a richer earnings multiple. The exact mix may surprise you.</p> <p><strong>Result: Fair Value of CHF 87.69 (UNDERVALUED)</strong></p> <p>Have a read of the narrative in full and understand what's behind the forecasts.</p> <p>However, this hinges on commodity costs and consumer demand. Sustained margin pressure or weaker volumes in key regions could be enough to quickly challenge that underpriced story.</p> <p>Find out about the key risks to this Nestlé narrative.</p> <h2>Another way to look at Nestlé's valuation</h2> <p>The fair value of CHF 87.69 comes from analyst earnings assumptions, but the SWS DCF model points to a very different picture, with an estimate of CHF 156.18 and Nestlé trading at a 49.4% discount. When two methods are this far apart, which one would you lean on?</p> <p>Look into how the SWS DCF model arrives at its fair value.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/dcf/query-ZGF0ZT0yMDI2LTA1LTAy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8dbe15b8-4f0f-4b69-bfb2-7a35503076db/chart/dcf/query-ZGF0ZT0yMDI2LTA1LTAy"/><figcaption>NESN Discounted Cash Flow as at May 2026</figcaption></figure><h2>Next Steps</h2> <p>Balancing signs of value with both risks and rewards can feel finely poised, so it helps to review the full picture quickly and decide where you stand by weighing up 3 key rewards and 1 important warning sign.</p> <h2>Ready to hunt for your next idea?</h2> <p>If Nestlé has you thinking more broadly about where returns could come from, do not stop here. Use the screener to size up fresh opportunities before others do.</p> <ul> <li>Target resilient compounding potential by focusing on dependable payers through the 479 dividend fortresses that puts reliable income front and center.</li> <li>Zero in on value opportunities early with the 242 high quality undervalued stocks that highlights companies combining quality fundamentals with market pessimism.</li> <li>Spot tomorrow's stories today using the screener containing 563 high quality undiscovered gems that focuses on quality businesses still flying under most investors' radar.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Nestlé might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

NSRGY

NSRGF

FTXG

<p>Nestlé (SWX:NESN) reported a Q1 2026 sales drop to CHF 21,317 million from CHF 22,601 million a year prior, yet shares rose due to strong organic growth. The stock trades at CHF 79.05, indicating a 49% discount to its fair value of CHF 87.69. Analysts suggest Nestlé's focus on premium health brands could drive growth, despite risks from commodity costs and demand fluctuations. A DCF model estimates a fair value of CHF 156.18, highlighting valuation discrepancies. The article emphasizes the importance of assessing risks and rewards in investment decisions.</p>

Simplywall

Nestlé

Nestlé S.A.

First Trust NASDAQ Food & Beverage

Invesco Food & Beverage ETF

SPDR FD Consumer Staples

VG Consumer Stap

iShares US Consumer Staples ETF

Assessing Nestlé (SWX:NESN) Valuation After Q1 Sales Drop And Resilient Organic Growth